ArticleMedical oncology (Northwood, London, England)2024

Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells.

Kantasorn Horpratraporn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.